ArticleJournal of cancer research and clinical oncology2025
Clinical outcome and genomic biomarkers of immune checkpoint inhibitor-based therapies for cancer of unknown primary: a multicenter, real-world study.
Yunjie Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.